Recognition memory and β-amyloid plaques in adult Tg2576 mice are not modified after oral exposure to aluminum

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 2, 2012, Pages 179-185

  Ribes, Diana ^a   Torrente, Margarita ^a   Vicens, Paloma ^a   Colomina, Maria Teresa ^a   Gómez, Mercedes ^a   Domingo, José L ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

amyloid; aluminum; corticosterone; functional observational battery; novel object recognition; Tg2576 mice

Indexed keywords

ALUMINUM; AMYLOID PRECURSOR PROTEIN; CORTICOSTERONE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CEREBELLUM; CLIMBING; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRINKING; EATING; FRONTAL CORTEX; GAIT; GENOTYPE; HABITUATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOGNITION; REFLEX; SENSORIMOTOR FUNCTION; TASK PERFORMANCE; WILD TYPE;

ADMINISTRATION, ORAL; AGING; ALUMINUM COMPOUNDS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; LACTATES; MALE; MEMORY; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; RECOGNITION (PSYCHOLOGY);

EID: 84861458893     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3182211ab1     Document Type: Article

References (58)

1. Gupta VB., Anitha S., Hegde ML., et al. Aluminium in Alzheimer's disease: are we still at a crossroad? Cell Mol Life Sci. 2005;62:143-158. (Pubitemid 40193039)
2. Fuentealba RA., Farias G., Scheu J., et al. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease. Brain Res Rev. 2004;47:275-289. (Pubitemid 39574325)
3. Gra S., Padró n N., Llibre JJ. Amyloid-beta peptide., tau protein and Alzheimer's disease. Rev Cubana Invest Biomed. 2002;21: 253-261. (In Spanish).
4. Gong G., O'Bryant SE. The arsenic exposure hypothesis for alzheimer disease. Alzheimer Dis Assoc Disord. 2010;24: 311-316.
5. Dunn N., Mullee M., Perry VH., et al. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord. 2005;19:91-94. (Pubitemid 41073086)
6. Kawahara M., Kato M., Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull. 2001;55: 211-217. (Pubitemid 32722161)
7. Rodella LF., Ricci F., Borsani E., et al. Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain. Histol Histopathol. 2008;23:433-439. (Pubitemid 351552328)
8. Becaria A., Lahiri DK., Bondy SC., et al. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J Neuroimmunol. 2006;176:16-23. (Pubitemid 44080334)
9. Panda SK., Baluska F., Matsumoto H. Aluminum stress signaling in plants. Plant Signal Behav. 2009;4:592-597.
10. Fuma S., Ishii N., Takeda H., et al. Ecological effects of various toxic agents on the aquatic microcosm in comparison with acute ionizing radiation. J Environ Radioact. 2003;67:1-14. (Pubitemid 36294065)
11. Sinczuk-Walczak H., Szymczak M., Razniewska G., et al. Effects of occupational exposure to aluminum on nervous system: clinical and electroencephalographic findings. Int J Occup Med Environ Health. 2003;16:301-310. (Pubitemid 38141866)
12. Sinczuk-Walczak H., Matczak W., Razniewska G., et al. Neurologic and neurophysiologic examinations of workers occupationally exposed to aluminium. Med Pr. 2005;56:9-17. (In Polish). (Pubitemid 40528939)
13. Saiyed SM., Yokel RA. Aluminium content of some foods and food products in the USA., with aluminium food additives. Food Addit Contam. 2005;22:234-244. (Pubitemid 40778722)
14. Golub MS., Germann SL., Han B., et al. Lifelong feeding of a high aluminum diet to mice. Toxicology. 2000;150:107-117.
15. Nayak P. Aluminum: impacts and disease. Environ Res. 2002;89:101-115. (Pubitemid 34680879)
16. Weiner MF., Vobach S., Olsson K., et al. Cortisol secretion and Alzheimer's disease progression. Biol Psychiatry. 1997;42: 1030-1038. (Pubitemid 27496434)
17. Dong H., Yuede CM., Yoo HS., et al. Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice. Neuroscience. 2008;155: 154-163.
18. Davis KL., Davis BM., Greenwald BS., et al. Cortisol and Alzheimer's disease., I: Basal studies. Am J Psychiatry. 1986; 143:300-305. (Pubitemid 16034087)
19. Peskind ER., Wilkinson CW., Petrie EC., et al. Increased CSF cortisol in AD is a function of APOE genotype. Neurology. 2001;56:1094-1098. (Pubitemid 32336320)
20. Csernansky JG., Dong H., Fagan AM., et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry. 2006;163:2164-2169. (Pubitemid 46114238)
21. Mullan M., Crawford F., Axelman K., et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992;1:345-347.
22. Hsiao K., Chapman P., Nilsen S., et al. Correlative memory deficits., Abeta elevation., and amyloid plaques in transgenic mice. Science. 1996;274:99-102. (Pubitemid 26332733)
23. Westerman M.A., Cooper-Blacketer D., Mariash A., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci. 2002;22:1858-1867. (Pubitemid 35386304)
24. Sills RC., Valentine WM., Moser V., et al. Characterization of carbon disulfide neurotoxicity in C57BL6 mice: behavioral., morphologic., and molecular effects. Toxicol Pathol. 2000;28: 142-148. (Pubitemid 30078216)
25. Franco-Pons N., Torrente M., Colomina MT., et al. Behavioral deficits in the cuprizone-induced murine model of demyelination/ remyelination. Toxicol Lett. 2007;169:205-213. (Pubitemid 46436370)
26. Herr DW., Graff JE., Moser VC., et al. Inhalational exposure to carbonyl sulfide produces altered brainstem auditory and somatosensory-evoked potentials in Fischer 344N rats. Toxicol Sci. 2007;95:118-135. (Pubitemid 44942783)
27. Golub MS., Germann SL., Lloyd KC. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav Brain Res. 2004;153:159-170. (Pubitemid 38829299)
28. de Lima MN., Luft T., Roesler R., et al. Temporary inactivation reveals an essential role of the dorsal hippocampus in consolidation of object recognition memory. Neurosci Lett. 2006;405:142-146. (Pubitemid 44142833)
29. Gomez M., Esparza JL., Cabre M., et al. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice., a model for Alzheimer's disease. Toxicology. 2008;249:214-219.
30. Kotilinek LA., Bacskai B., Westerman M., et al. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci. 2002;22:6331-6335. (Pubitemid 35386387)
31. Encinas JM., Enikolopov G. Identifying and quantitating neural stem and progenitor cells in the adult brain. Methods Cell Biol. 2008;85:243-272.
32. Markgraf CG., Cirino M., Meredith J. Comparison of methods for analysis of functional observation battery (FOB) data. J Pharmacol Toxicol Methods. 2010;62:89-94.
33. Strong MJ., Garruto RM., Joshi JG., et al Can the mechanisms of aluminum neurotoxicity be integrated into a unified scheme? J Toxicol Environ Health. 1996 48 599-613.
34. Kilburn KH. Neurobehavioral impairment and symptoms associated with aluminum remelting. Arch Environ Health. 1998;53:329-335. (Pubitemid 28443452)
35. Yokel RA. The toxicology of aluminum in the brain: a review. Neurotoxicology. 2000;21:813-828.
36. Bondy SC. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology. 2010;31:575-581.
37. Klein GL. Aluminum: new recognition of an old problem. Curr Opin Pharmacol. 2005;5:637-640. (Pubitemid 41614465)
38. Llobet JM., Domingo JL., Gomez M., et al. Acute toxicity studies of aluminium compounds: antidotal efficacy of several chelating agents. Pharmacol Toxicol. 1987;60:280-283. (Pubitemid 17064148)
39. Xu H., Yang HJ., Zhang Y., et al. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. Behav Neurosci. 2009;123:418-429.
40. Milanese M., Lkhayat MI., Zatta P. Inhibitory effect of aluminum on dopamine beta-hydroxylase from bovine adrenal gland. J Trace Elem Med Biol. 2001;15:139-141. (Pubitemid 33150862)
41. Wenk GL., Stemmer KL. The influence of ingested aluminum upon norepinephrine and dopamine levels in the rat brain. Neurotoxicology. 1981;2:347-353. (Pubitemid 12149470)
42. Kim S., Nam J., Kim K. Aluminum exposure decreases dopamine D1 and D2 receptor expression in mouse brain. Hum Exp Toxicol. 2007;26:741-746. (Pubitemid 350157343)
43. Good M.A., Hale G., Staal V. Impaired "episodic-like" object memory in adult APPswe transgenic mice. Behav Neurosci. 2007;121:443-448. (Pubitemid 47445097)
44. Ognibene E., Middei S., Daniele S., et al. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behav Brain Res. 2005;156:225-232. (Pubitemid 39576062)
45. Taglialatela G., Hogan D., Zhang WR., et al. Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res. 2009;200:95-99.
46. Ribes D., Colomina MT., Vicens P., et al. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp Neurol. 2008;214:293-300.
47. Foy MR., Stanton ME., Levine S., et al. Behavioral stress impairs long-term potentiation in rodent hippocampus. Behav Neural Biol. 1987;48:138-149.
48. Diamond DM., Bennett MC., Fleshner M., et al. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 1992;2:421-430.
49. Pavlides C., Watanabe Y., McEwen BS. Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus. 1993;3:183-192. (Pubitemid 23130074)
50. Xu L., Holscher C., Anwyl R., et al. Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticity by stress. Proc Natl Acad Sci U S A. 1998;95:3204-3208. (Pubitemid 28135880)
51. Akirav I., Richter-Levin G. Biphasic modulation of hippocampal plasticity by behavioral stress and basolateral amygdala stimulation in the rat. J Neurosci. 1999;19:10530-10535. (Pubitemid 30228059)
52. Maroun M., Richter-Levin G. Exposure to acute stress blocks the induction of long-term potentiation of the amygdala-prefrontal cortex pathway in vivo. J Neurosci. 2003;23:4406-4409. (Pubitemid 36706170)
53. Mostafa RM., Mostafa YM., Ennaceur A. Effects of exposure to extremely low-frequency magnetic field of 2 G intensity on memory and corticosterone level in rats. Physiol Behav. 2002;76:589-595. (Pubitemid 34786686)
54. Pratico D., Uryu K., Sung S., et al. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 2002;16:1138-1140.
55. Sakamoto T., Ogasawara Y., Ishii K., et al. Accumulation of aluminum in ferritin isolated from rat brain. Neurosci Lett. 2004;366:264-267. (Pubitemid 39024278)
56. Sanchez-Iglesias S., Soto-Otero R., Iglesias-Gonzalez J., et al. Analysis of brain regional distribution of aluminium in rats via oral and intraperitoneal administration. J Trace Elem Med Biol. 2007;21:31-34. (Pubitemid 350138403)
57. Kawarabayashi T., Younkin LH., Saido TC., et al. Agedependent changes in brain., CSF., and plasma amyloid b protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001;21:372-381. (Pubitemid 32107428)
58. Irizarry M., McNamara M., Fedorchack K., et al. APPsw transgenic mice develop age-related Ab deposits and neurophil abnormalities., but no neuronal loss in CA1. J Neuropathol Exp Neurol. 1997;56:965-973. (Pubitemid 27386126)